Concord Drugs Limited (BOM:538965)

Concord Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,121	311	352	256	254	254
Market Cap Growth	200.38%	-11.63%	37.54%	0.84%	-0.17%	146.63%
Enterprise Value	1,309	501	521	428	362	351
Last Close Price	85.11	31.08	35.17	27.45	29.00	29.05
PE Ratio	147.15	92.45	74.47	25.95	15.91	7.74
PS Ratio	2.49	0.69	0.78	0.49	0.43	0.49
PB Ratio	3.26	0.91	1.04	0.81	0.89	0.95
P/TBV Ratio	3.26	0.91	1.04	0.81	0.89	0.95
P/FCF Ratio	26.52	22.37	-	31.71	-	-
P/OCF Ratio	17.46	8.35	44.39	15.38	32.75	1567937.89
EV/Sales Ratio	2.90	1.11	1.16	0.82	0.61	0.68
EV/EBITDA Ratio	28.83	12.12	12.88	9.36	6.37	10.63
EV/EBIT Ratio	42.42	18.54	20.93	14.52	9.24	18.11
EV/FCF Ratio	30.96	36.08	-	53.05	-	-
Debt / Equity Ratio	0.56	0.56	0.52	0.54	0.58	0.49
Debt / EBITDA Ratio	4.22	4.65	4.33	3.71	2.89	3.92
Debt / FCF Ratio	4.53	13.85	-	21.04	-	-
Net Debt / Equity Ratio	0.55	0.56	0.51	0.53	0.58	0.48
Net Debt / EBITDA Ratio	4.14	4.60	4.29	3.69	2.88	3.91
Net Debt / FCF Ratio	4.44	13.69	-76.85	20.91	-9.73	-3.52
Asset Turnover	0.64	0.73	0.77	0.91	1.11	0.95
Inventory Turnover	1.42	1.48	1.57	2.22	2.90	3.07
Quick Ratio	0.59	0.53	0.61	0.74	0.97	1.28
Current Ratio	1.55	1.56	1.79	2.01	1.77	2.22
Return on Equity (ROE)	1.69%	0.99%	1.44%	3.28%	5.78%	13.06%
Return on Assets (ROA)	2.72%	2.73%	2.66%	3.21%	4.60%	2.25%
Return on Invested Capital (ROIC)	3.29%	2.52%	3.75%	4.98%	6.58%	4.08%
Return on Capital Employed (ROCE)	7.90%	6.90%	6.60%	8.00%	11.90%	5.80%
Earnings Yield	0.51%	1.08%	1.34%	3.85%	6.29%	12.92%
FCF Yield	3.77%	4.47%	-0.64%	3.15%	-6.63%	-14.46%
Buyback Yield / Dilution	4.27%	-	-7.35%	-6.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.